Neuroscience

Parkinson’s Disease Models

Biocytogen has constructed a mouse with an A53T mutant SNCA gene, a B-CAG hSNCA*A53T mice, for preclinical Parkinson's disease research.

on this page

  • Parkinson's Disease Mouse Model Introduction
  • Results

Publication

    Parkinson's Disease Mouse Model Introduction

    Parkinson's disease(PD) is the most common serious movement disorder in the world, affecting about 1% of adults over the age of 60. The main pathological change of PD is the progressive loss of dopaminergic neurons in the substantia nigra dense region accompanied by a decrease in striatal dopamine levels, but the specific pathogenesis of PD is not clear. The pathogenesis of PD and the relationship between various targets are still a hot topic in current research, so the preparation of mouse models plays a pivotal role in the study of PD in basic research. The Alpha-Synuclein Gene (SNCA) is the first gene to be found to be associated with familial PD, and its encoding α-syn is a soluble protein expressed in the central nervous system presynaptic and perinuclear and is also a major component of Lewy bodies in neurons of PD patients. Genome-wide association analysis showed that SNCA was closely related to the pathogenesis of PD, and the high expression of SNCA gene was an important pathological marker of PD. Point mutations in SNCA genes, such as A53T, A30P, E46K, G51D and H50Q, are closely related to the occurrence of PD, and A53T mutations lead to the formation of more amyloid fibrils in α-syn. Biocytogen has constructed a mouse with an A53T mutant SNCA gene, a B-CAG hSNCA*A53T mice, for preclinical Parkinson's disease research.

    Results
    Behavior test of B-hSCNA53T mice (Parkinson's disease)

    Modeling design

    Group Animal Number of animals Age Open field EPM Rotarod Tests Grip strength
    G1 B-hSCNA53T; Male 8 6 weeks Day 1
    Free explore for 10 min
    Day 2
    Free explore for 10 min
    Day 2-5
    15 rpm/min
    Day 6
    G2 B-hSCNA53T; Female 8 6 weeks
    G3 C57BL/6; Male 8 6 weeks
    G4 C57BL/6 Female 8 6 weeks
    Behavior test of B-hSCNA53T mice (Parkinson‘s disease) (6-7 weeks)

    Open field test (OF)

    Figure1. Hyperactivity in open field test. B-hSCNA53T mice travel more distanceand show higher velocity.

    Rotarod test

    Figure2. Total distance and times of B-hSCNA53T mice on rotarod was lower than that of WT mice.

    Grip strength

    Figure3. Grip strength of of B-hSCNA53T mice was lower than that of WT mice.

    Elevated Plus Maze (EPM)

    Figure4. No difference was observed on EPM between B-hSCNA53T and WT mice.

    Expression of human a-synuclein (haSyn) in B-hSNCA*A53T

    Expression, localization of human a-synuclein (haSyn) in central nervous system (CNS). (A) B-hSNCA*A53T mice. (B) C57BL/6 mice. Red box: Striatum; Green box: Hippocampus; Yellow box:Substantial nigra